Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and the effects of GH-releasing hormone and somatostatin. 1994

N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
Department of Endocrinology, Kobe City General Hospital, Japan.

We investigated in five normal subjects whether the secretion of GH from lymphocytes would occur spontaneously without mitogens and be regulated by GHRH and somatostatin as in the endocrine system. Peripheral blood mononuclear cells were isolated from heparinized blood by the standard Ficoll-Hypaque gradient centrifugation method, and incubated for up to 7 days with or without GHRH, somatostatin analog (SMS 201-995), cycloheximide, or actinomycin D. GH levels in the lyophilized samples were measured by a highly sensitive enzyme immunoassay. GH concentration in culture medium (5 x 10(5) cells/mL) time dependently increased in all subjects, reaching 0.47 +/- 0.18 ng/L at day 7. A protein synthesis inhibitor (cycloheximide) and RNA synthesis inhibitor (actinomycin D) completely blocked GH secretion from lymphocytes. Immunoreactive GH secreted by unstimulated human lymphocytes was similar to pituitary GH in terms of antigenicity and molecular weight. Physiological concentrations of GHRH (10(-10)-10(-8) mol/L) and SMS 201-995 (10(-8)-10(-6) mol/L) had no effects on the spontaneous secretion of GH from human lymphocytes. These results indicate that GH is spontaneously synthesized de novo and secreted from unstimulated human lymphocytes, and that the regulation of GH in the immune system differs from that in the endocrine system.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
January 1999, Neuroendocrinology,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
May 1993, The Journal of clinical endocrinology and metabolism,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
July 1986, The Journal of clinical endocrinology and metabolism,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
July 1990, The Journal of clinical endocrinology and metabolism,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
October 1989, The Journal of clinical endocrinology and metabolism,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
March 1989, The Journal of clinical endocrinology and metabolism,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
April 1990, Biochemical and biophysical research communications,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
August 2000, The Journal of clinical endocrinology and metabolism,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
February 1988, The Journal of clinical endocrinology and metabolism,
N Hattori, and K Ikekubo, and T Ishihara, and K Moridera, and M Hino, and H Kurahachi
September 1998, Endocrinology,
Copied contents to your clipboard!